Back to results
US 11,376,247 B2Granted
Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
AssigneeThe Regents of the University of Colorado, a body corporate
InventorsMary Reyland, Sten Wie
Life of this patent
Estimating the term…
Abstract
Methods for inducing the regeneration of non-cancerous tissues in a cancer patient undergoing radiotherapy and/or chemotherapy using continuous administration of tyrosine kinase inhibitors for at least 90 days following a cancer treatment in the patient.
Claims8
A method for regenerating non-cancerous cells following treatment of a cancer patient, the method comprising administering a therapeutically effective amount of a tyrosine kinase inhibitor (TKI) for several months after administering a cancer treatment to the cancer patient.
Dependencies are inferred from the claim text.